Supernus announces Q2 2024 earnings date: Aug 6 after market close

SUPERNUS PHARMACEUTICALS, INC.

Q2 2024 financial and business results to be reported after market close on Tuesday, August 6, 2024.
CEO Jack Khattar and CFO Tim Dec will host a conference call at 4:30 p.m. ET on August 6.
Live webcast available on Supernus investor relations website; replay accessible for 60 days.
No preliminary financial results or guidance were provided in this announcement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.